• Developing Technology for the Future and Delivering viable Solutions Today

    Tamarisk Technologies is revolutionizing industries with it's cutting edge solutions.

  • Serum-Specific Drug Transport Vehicle, Oral Route

    Our New Drug Delivery Technology Delivers up to 95% of the therapeutic payload... Now Available

  • Tissue Specific Drug Delivery Vehicle

    "Once in a lifetime, a technology comes along with the true potential to change the world. This is one of those technologies" Now Available

  • Rapidly Biodegradable Plastics are Here!

    Our new plastic is biodegradable in 60 days... another ground-breaking technology developed by Tamarisk Technologies. Now Available

  • The Tamarisk Revolution Has Begun

    It is said, "there is an appointed time for everything. And there is a time for every event under heaven." Well, this is the time for Tamarisk.

DelivRX

In 2011, Tamarisk assigned it's SSNe patent and related technologies to its licensing arm, DelivRx, Inc., a Nevada corporation in which Tamarisk has acquired 70% ownership. DelivRx is actively engaged in working with major pharmaceutical and related companies to license the technology for utilization over a broad panoply of applications.

For more information about Tamarisk's Serum Specifc, Tissue Specific, and Extended Release technologies, contact the DelivRX team today at licensing@tamarisktech.com or call our office at 405-279-1250.

 

Related Articles

Serum-Specific Drug Transport- Click Here

Oral Insulin Report- Click Here

Oral Peptide YY 3-36 - Click Here

Oral Tumore Necrosis Factor - Coming Soon

Oral Herceptin - Coming Soon

Oral Pegylated Interferon - Coming Soon

 

 

 

The documents on this web site could include technical inaccuracies or typographical errors. Please report any errors to Tamarisk Technologies Customer Service